Study on the Efficacy Mechanism of Natural Psychotherapy for Neurosis

NCT ID: NCT05552014

Last Updated: 2024-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-01

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

explore objective indicators of the efficacy of natural psychotherapy in the treatment of disorders such as obsessive-compulsive disorder

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. To evaluate the cognitive function, Cognitive control, emotion and other aspects of neurosis patients, and to understand and master the cognitive behavior indicators of this population.
2. Investigate the pathological mechanism of neurotic patients from the aspects of EEG/fMRI and biology.
3. To investigate the therapeutic effect of natural psychotherapy on cognitive impairment and related mood, sleep and symptom intervention in neurotic patients. In order to achieve the symptoms of neurosis patients, cognitive impairment and related mood and sleep intervention and promotion, while providing a scientific basis for neurosis rehabilitation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obsessive-Compulsive Disorder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

obsessive-compulsive disorder natural psychotherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
The patient was assigned to either the intervention group or the control group, but the control group would also receive treatment after a two-month waiting period. Therefore, the patient was only informed whether they would be participating in the first or second intervention.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Natural Psychotherapy

Intervention using natural psychotherapy for OCD patients for two to three hours once a week for eight weeks

Group Type ACTIVE_COMPARATOR

Natural Psychotherapy

Intervention Type BEHAVIORAL

Natural psychotherapy is based on "Morita therapy" and is a psychotherapy that fully reflects the characteristics of Chinese culture, taking into account the Chinese cultural background and actual clinical characteristics.

Mental Health Education

Mental health education was given to another group of OCD patients for two hours once a week for eight weeks

Group Type PLACEBO_COMPARATOR

Mental Health Education

Intervention Type BEHAVIORAL

Mental Health Education Seminar

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Natural Psychotherapy

Natural psychotherapy is based on "Morita therapy" and is a psychotherapy that fully reflects the characteristics of Chinese culture, taking into account the Chinese cultural background and actual clinical characteristics.

Intervention Type BEHAVIORAL

Mental Health Education

Mental Health Education Seminar

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* were between 16 and 55 years old;
* were diagnosed with OCD by an experienced psychiatrist utilizing the Structured Clinical Interview for DSM-5 (SCID);
* had an illness duration of at least 12 months;
* were able to participate in the entire trial and face-to-face on-site assessment

Exclusion Criteria

* pregnant or breastfeeding;
* suffered from organic brain diseases or severe physical illness;
* had a history of substance or alcohol abuse
* were at high risk of suicide
Minimum Eligible Age

15 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing HuiLongGuan Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xiang Yang Zhang

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xiang Y Zhang, M.D, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Institute of Psychology, Chinese Academy of Science

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Anhui Mental Health Center

Hefei, Anhui, China

Site Status RECRUITING

Institute of Psychology, Chinese Academy of Sciences

Beijing, China, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xiang Y Zhang, M.D., Ph.D

Role: CONTACT

Phone: +86-10-62710644

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xiangyang Zhang, Ph.D, MD

Role: primary

Xiang Y Zhang, M.D.,Ph.D

Role: primary

Xiang Y Zhang, M.D.,Ph.D

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CASPsy5

Identifier Type: -

Identifier Source: org_study_id